Speaker Profile
Ph.D., Vice President of Computational Biology,
Biography
A pioneer in data science and computational biology, Olga Sazonova translates moonshot RD into market-moving products in consumer genomics, cancer detection, and personalized nutrition.During her Biomedical Engineering PhD at Boston University, Olga taught herself to code, earning a coveted NIH postdoctoral fellowship in computational science at Stanford. Balancing motherhood with her biotech career, she joined 23andMe, first leading massive genomic studies in neurological disease before moving to the product team to build the core machine learning models for their consumer polygenic risk scores. At GRAIL, she spearheaded the RD for novel AI-driven early cancer detection.As Director of Data Science at Nutrisense, Olga built the research program from scratch, directing IRB-approved clinical studies and unleashing LLMs to validate product efficacy. At Xella Health, she now leads a team of scientists and engineers developing the first AI-driven, multi-omics powered 'magnifying lens' to illuminate female reproductive health and biology.
Talk
Decoding the Female Healthspan Through Menstrual Fluid
Xella is pioneering a breakthrough method to monitor reproductive health using menstrual fluid instead of invasive biopsies. By using long-read DNA sequencing and proprietary computational methods, we can now separate and analyze "biological aging" signals from the reproductive system versus immune cells, revealing how reproductive organs age differently than the rest of the body.
Spatial Showcase:
Xella Health, PBC
Xella Health is a precision healthcare platform for women that leverages multi-omics, AI, and non-invasive testing to provide proactive prevention and early detection for gynecological disease. The company offers a convenient, personalized experience through an integrated patient portal and expert clinician team, ensuring that both patients and providers can easily interpret and act on predictive health insights.
